Abstract
Stereotactic body radiation therapy (SBRT) for intra-thoracic malignancies continues to be an evolving therapeutic option for many cancer patients. Due to the high dose per fraction delivered, such treatments also deposit significant doses within the chest wall, potentially resulting in inflammation, pain, or rib fracture. We investigated the potential associations between these complications with chest wall dose and post-treatment positron emission tomography (PET) SUV in patients treated with thoracic SBRT.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: International Journal of Radiation Oncology*Biology*Physics
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
